Because cannabis withdrawal symptoms overlap with common MS-related complaints, clinicians should differentiate among MS-related symptom fluctuations and effects associated with cannabis cessation when evaluating new or worsening symptoms.
In people with multiple sclerosis, greater resilience was associated with more physical activity, which in turn was connected to better functional capabilities. Resilience did not directly impact functioning after considering factors such as mood and fatigue.
Although intravenous anti-CD20 therapies have shown benefits beyond their standard dosing schedule, the long-term effects of ofatumumab, an anti-CD20 therapy with a shorter half-life, are less understood.
Cognitive and psychological factors may contribute to balance performance and could be considered when interpreting fall risk in clinical assessments.
Though they fluctuate, hope and positivity comfort people with multiple sclerosis as their circumstances change and they progress toward end-of-life discussions and planning.
Arterial stiffness is associated with aging, obesity, comorbidities, and cardiovascular disease in the general population and needs to be further studied in people with MS.